Preliminary Efficacy and Safety of the CK1ε/PI3Kδ Dual Inhibitor HZ-H08905 in Patients with Relapsed and/or Refractory B-Cell Lymphomas: Results from the Phase 1 HZ-H08905-101 Study
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Juying Wei, Wenjuan Yu, Zhengming Jin, Keshu Zhou, Haiyan Yang, Fei Li, Lanfang Li, Bo Zhang, Miao Hu, Yanping Zhang, Xinglu Zhou, Jie Jin
Institutions: First Affiliated Hospital Zhejiang University, Soochow University, First Affiliated Hospital of Soochow University, Henan Cancer Hospital, Zhejiang Cancer Hospital, University of Chinese Academy of Sciences, First Affiliated Hospital of Jiangxi Medical College, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Westlake University, Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine, Zhejiang University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405039794